Stratos Wealth Partners, Ltd. Tg Therapeutics, Inc. Transaction History

Stratos Wealth Partners, Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 24, 2024	BUY	$6.68 - $18.81 $48,931 - $137,783	7,325 Added 70.23%	17,755 $303,000
Q3 2023 Oct 24, 2023	BUY	$8.36 - $26.5 $87,194 - $276,395	10,430 New	10,430 $87,000
Q4 2018 Feb 08, 2019	SELL	$3.44 - $5.76 $688 - $1,152	-200 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$5.15 - $14.0 $1,030 - $2,800	200 New	200 $1,000
Q2 2018 Aug 13, 2018	SELL	$12.5 - $15.0 $7,875 - $9,450	-630 Closed	0 $0
Q1 2018 May 10, 2018	BUY	$8.7 - $16.8 $5,481 - $10,584	630 New	630 $9,000

347

88M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.85B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Stratos Wealth Partners, Ltd., based on Form 13F filings with the SEC.

Stay updated on Stratos Wealth Partners, Ltd. with notifications on news.